Search results for: 'Companies-To-Action'
- Did you mean
- companies to activ
- companies to active
-
31 Oct 2017  |  Global  |  Market Research
Global Digital Pathology Market, 2017 Companies-To-Action
Collaborative Business Models Embracing Artificial Intelligence Application in Novel Disease Areas to Drive Market Growth
It is estimated that more than 19,000 pathologists would be needed to serve the US healthcare needs. However, the actual number is expected to be approximately 40% lesser. Similar trends are foreseen globally driven by aging population and widening application in areas such as cancer diagnostics, drug development, clinical trials, biomarker discove...
$3,000.00
Special Price $2,250.00 save 25 %
-
21 Aug 2018  |  Global  |  Market Research
Artificial Intelligence for Medical Image Analysis—Companies-to-Action, 2018
Lay of the Land, Growth Opportunities and Future Direction
Medical imaging has become the bellwether application for artificial intelligence (AI) technologies in healthcare. From deep learning and machine learning approaches, to cognitive computing, to even natural language processing, several AI approaches are now being incorporated in the field of radiology. Apart from academic research groups, almost al...
$3,000.00
Special Price $2,250.00 save 25 %
-
17 May 2024  |  Global  |  Market Research
Emerging Respiratory Care Companies: Strategic Profiles and Growth Opportunities
Digital Respiratory Solutions will Drive the Respiratory Care Industry in its Next Growth Phase
This study highlights emerging companies in the respiratory care industry. Most respiratory care companies focus on device connectivity and developing smart devices that can assist in better management of chronic respiratory diseases and reduce healthcare costs. The COVID-19 pandemic increased the focus on the benefits of remote care. Respiratory s...
$2,450.00
Special Price $1,837.50 save 25 %
-
28 May 2024  |  Global  |  Market Research
Strategic Profiles of Emerging Companies in the Cardiovascular Devices Market
Real-time Continuous Monitoring, Hospital Segment for Wearables, and AI to Drive the Next Growth Phase
This study highlights emerging companies in the cardiovascular space. Cardiovascular disease detection and monitoring have been gaining significant attention considering rising healthcare costs and challenges related to the availability of a skilled healthcare workforce. Companies are trying to address these challenges with technology-driven so...
$2,450.00
Special Price $1,837.50 save 25 %
-
29 Aug 2022  |  Global  |  Technology Research
Advancements in miRNA: Technology Assessment
Developments in miRNA sequencing and analysis are driving future growth potential in therapeutics and diagnostics
Accelerated research around RNA-based therapeutics and diagnostics, accompanied by technology advancements in sequencing the human genome, has resulted in a better understanding of the role of miRNA in biological pathways, enhancing its potential in both therapeutics and diagnostics. The successful clinical validation of miRNA diagnostic tests has ...
$4,950.00
Special Price $3,712.50 save 25 %
-
24 Nov 2005  |  Global  |  Market Research
Market Strategies for Top Pharmaceutical Companies
This research service analyses the market strategies for top pharmaceutical companies.
$3,950.00
Special Price $2,962.50 save 25 %
-
12 Jun 2024  |  Global  |  Market Research
Innovative AI-enabled Clinical Trial Companies: Strategic Profiling and Growth Opportunities
The Integration of Real-world Insights into Trial Management is Propelling AI Adoption in Clinical Trials
As global clinical pipelines witness a surge in complex novel therapies, there is a general inclination toward improving trial design through adaptive trial designs with technology-enabled solutions for planning and execution. Artificial intelligence (AI) is gaining large-scale recognition in terms of supporting decentralized trial designs and allo...
$2,450.00
Special Price $1,837.50 save 25 %
-
27 Aug 2026  |  Global  |  Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, presenting opportunities for innovation. There has been a...
$4,950.00 -
26 Apr 2019  |  Global  |  Market Research
Artificial Intelligence—Top 10 Applications in Healthcare, Global, 2018–2022
Exploring Key Investment Trends, Companies-to-Action, and Growth Opportunities for AI in the Healthcare Industry
Artificial intelligence (AI) is exhibiting real promise across multiple industries. The healthcare industry is leading the charge when it comes to focused AI application development and attracting AI investment globally. With improvements in healthcare data acquisition and computing power, AI is becoming more of a reality each day. Frost & Sullivan...
$1,500.00
Special Price $1,125.00 save 25 %
-
25 Jul 2024  |  Global  |  Frost Radar
Frost Radar™: Clinical-Grade Wearables, 2024
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Clinical-grade wearables are regulatory-approved devices that provide clinically actionable data for monitoring, diagnostic, and therapeutic applications. As demand for continuous remote monitoring of patients increases to mitigate healthcare challenges, such as rising costs and staff shortages, so will the potential for wearable devices to support...
$4,950.00
Special Price $3,712.50 save 25 %